Lanean...
Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with ovarian cancer
This is the protocol for a review and there is no abstract. The objectives are as follows: To compare the effectiveness and safety of weekly paclitaxel with that of three‐weekly paclitaxel, in combination with carboplatin, as first‐line chemotherapy treatment for ovarian cancer.
Gorde:
| Argitaratua izan da: | Cochrane Database Syst Rev |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley & Sons, Ltd
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457624/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012007 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|